July 26, after market closed. Basically today

just bought 3M of key asic.. hahaha...

up in afternoon... some dato and tan sri buying

@gayauQwe, you damm kia si one huh!

when taikor loaded a lot in sell Q, it means ready to push up.. they don't want small timers to buy..

some taikor buying up... hot stock ma!!

@cinqueerre -- why sell now? time to buy more..

above 50 sen soon..............

@all hot hot hot!!!

who is the idiot put so much selling to block?

very strong fundamental, just beginning...buy and keep 1 year, it will double at least.

@gayauqwe - wow congrats, 25M shares is RM8m-10M wor... rich man now!

@ran77rpt good observation. Ucrest and Keyasic are complimentary, one is selling hardware with chips and ucrest is selling software services in heatlhcare. One side gets deal, the other side get deal for a deal that has hardware and software..

going to break 0.40 up up up

http://www.thesundaily.my/news/2018/07/19/ucrest-partners-russian-cancer-research-centre

http://www.thesundaily.my/news/2018/07/19/ucrest-partners-russian-cancer-research-centre

keyasic will fly also

bro stock going to fly, looks like...

http://www.theedgemarkets.com/article/ucrest-higher-high-says-alliancedbs-research

@huatai98 - u are welcome, bro

announcement yesterday from the bro stock

UCREST PARTNERS WITH BLOKHIN - THE LARGEST CANCER RESEARCH CENTER IN EUROPE

(19 July 2018, Kuala Lumpur) UCrest Berhad announced today that the Company has signed Memorandum of Understanding with Blokhin Russian Cancer Research Center, the largest cancer research center in Europe and one of the largest cancer research institutes in the world to bring online cancer research of protocols and medicines, collaboration with other doctors in other hospitals in research, clinical trials and provide medical services to patients, extending the medical services to every corner in the world through imedic™ platform.

Additionally, UCrest and Blokhin Cancer Research Center will jointly conduct research and development on cancer diagnosis and therapeutic using artificial intelligence (AI) technology, block chain and Internet of Things (IOT) technology in combating one of the deadliest and toughest diseases faced by mankind.

Through the D-to-D-to-P (Doctors to Doctors to Patients) or D-to-P (Doctors to Patients) models, cancer specialists or Multi-Discipline Team (MDT) from Blokhin Center will be able to provide diagnosis or second opinion and treatment plan to patients not just in Malaysia, but anywhere in the world.
“Technologies have always been the key part of medical science, particularly in the diagnosis and therapeutic of cancer. We are delighted to work with UCrest in the initiative to incorporate the latest technology of artificial intelligence and imedic into our research and clinic trial in addition to delivery of services to the patients,” said Dr. Meshcheryakov Andrey Albertovich, Deputy Director of Blokhin Center of Ministry of Health, Russia.
“Blokhin Center is one of the leading cancer research centers in the world and they have many successes and breakthroughs in many areas of the cancer diagnosis and therapeutic. We are leading in the use of IOT, Block Chain and artificial intelligence technologies in various aspects in the medical development, our collaboration will definitely bring one of the most advance technologies in cancer treatment to the people everywhere” said Mr. Eg Kah Yee Chairman of UCrest Berhad. “We are also planning to establish joint venture or any form of collaboration between Blokhin, UCrest and the local hospitals or clinics in offering the best possible treatment to the cancer patients,” he added.


About UCrest:

UCrest is the leading mobile health platform developer and operator with its imedic™ Cloud Hospital used by thousands of doctors and patients in the US, Russia, China and other Asian countries. imedic™ is powered by advanced Artificial Intelligence and knowledge-based technology for comprehensive analysis of the health data of the users to produce timely and accurate health information.
visit www.unitedcresthealthcare.com, www.palettemm.com


About N N Blokhin Cancer Research Center

Founded in 1951, the mission of Blokhin is to conduct fundamental and applied scientific research in the precancerous diseases and tumours while providing top quality medical care to patients. The institute undertakes research in the field of tumour cell biology, mechanisms of carcinogenesis and tumour progression (molecular, virological, chemical, physical, genetic, cellular, and immunological aspects). It also carries out experimental and clinical development of new technologies in surgical treatment of cancer, and works to develop new drugs and diagnostics, radiation and combined therapy, as well as researching preventative measures. A key specialist area of the unit is paediatric oncology.
Visit www.ronc.ru

UCREST PARTNERS WITH BLOKHIN - THE LARGEST CANCER RESEARCH CENTER IN EUROPE

(19 July 2018, Kuala Lumpur) UCrest Berhad announced today that the Company has signed Memorandum of Understanding with Blokhin Russian Cancer Research Center, the largest cancer research center in Europe and one of the largest cancer research institutes in the world to bring online cancer research of protocols and medicines, collaboration with other doctors in other hospitals in research, clinical trials and provide medical services to patients, extending the medical services to every corner in the world through imedic™ platform.

Additionally, UCrest and Blokhin Cancer Research Center will jointly conduct research and development on cancer diagnosis and therapeutic using artificial intelligence (AI) technology, block chain and Internet of Things (IOT) technology in combating one of the deadliest and toughest diseases faced by mankind.

Through the D-to-D-to-P (Doctors to Doctors to Patients) or D-to-P (Doctors to Patients) models, cancer specialists or Multi-Discipline Team (MDT) from Blokhin Center will be able to provide diagnosis or second opinion and treatment plan to patients not just in Malaysia, but anywhere in the world.
“Technologies have always been the key part of medical science, particularly in the diagnosis and therapeutic of cancer. We are delighted to work with UCrest in the initiative to incorporate the latest technology of artificial intelligence and imedic into our research and clinic trial in addition to delivery of services to the patients,” said Dr. Meshcheryakov Andrey Albertovich, Deputy Director of Blokhin Center of Ministry of Health, Russia.
“Blokhin Center is one of the leading cancer research centers in the world and they have many successes and breakthroughs in many areas of the cancer diagnosis and therapeutic. We are leading in the use of IOT, Block Chain and artificial intelligence technologies in various aspects in the medical development, our collaboration will definitely bring one of the most advance technologies in cancer treatment to the people everywhere” said Mr. Eg Kah Yee Chairman of UCrest Berhad. “We are also planning to establish joint venture or any form of collaboration between Blokhin, UCrest and the local hospitals or clinics in offering the best possible treatment to the cancer patients,” he added.


About UCrest:

UCrest is the leading mobile health platform developer and operator with its imedic™ Cloud Hospital used by thousands of doctors and patients in the US, Russia, China and other Asian countries. imedic™ is powered by advanced Artificial Intelligence and knowledge-based technology for comprehensive analysis of the health data of the users to produce timely and accurate health information.
visit www.unitedcresthealthcare.com, www.palettemm.com


About N N Blokhin Cancer Research Center

Founded in 1951, the mission of Blokhin is to conduct fundamental and applied scientific research in the precancerous diseases and tumours while providing top quality medical care to patients. The institute undertakes research in the field of tumour cell biology, mechanisms of carcinogenesis and tumour progression (molecular, virological, chemical, physical, genetic, cellular, and immunological aspects). It also carries out experimental and clinical development of new technologies in surgical treatment of cancer, and works to develop new drugs and diagnostics, radiation and combined therapy, as well as researching preventative measures. A key specialist area of the unit is paediatric oncology.
Visit www.ronc.ru

share price should be next year FY2019... I forecast their profit RM20M, at PE 15x = 300M.. share price today should be 0.65... cheap cheap by.. it is only PE of 7..

@profitmastery good analysis. You are absolutely right..

buy now, after that funds coming in liao

qtr financial out on 27 Jul after market close

dusti is right. Analysis shows selling for small profit because it is Fri afternoon...

last high was 0.31 I think. No reason why it should not pass that.

going strong today... stronger tomorrow

@tw01 - you are absolutely right. These guys have great inventions!! must give them thumbs up!!

RYC is going to replace the medical record book that polyclinics or hospital gives the pregnant Mom...

http://www.rsbctrade.com/key-asic-launched-ryc-ai-medicine-in-a-block-chain-drive/

http://www.rsbctrade.com/key-asic-launched-ryc-ai-medicine-in-a-block-chain-drive/

@harris lincoln yes..their Q4 is end May. 2 month to release Q result. so july.

website takes time for IT guys ma...

@nothingfree their IR sent to the list of investors who want to be on mailing list... you are send email to IR@keyasic.com to request to be added in.

RYC will be used by billions of ppl

Good announcement

KEY ASIC A FOUNDING MEMBER OF BRICS ARTIFICIAL INTELLIGENCE (AI) MEDICINE CONSORTIUM

(Kuala Lumpur, July 12, 2018) Following the latest product announcement of the AI Block Chain Device called Ramon Y Cajal or RYC, Key ASIC Berhad (Stock Code: 0143) announced today that it has spearheaded the formation of BRICS Artificial Intelligence Medicine Consortium (AI) in Shanghai, China. The BRICS countries consists of Brazil, Russia, India, China and South Africa. Key ASIC led the initiative and is a founding member of this consortium.
The signing ceremony was well represented and attended by high ranking officials from the BRICS countries including the Special Envoy of Deputy Prime Minister of Russia Dr. Vasilli Shpak, the Chairman of BRICS Bio-Medicine from Russia, Professor Shamil Akhmedov, Chairman of BRICS Bio-Medicine from India Professor Prakash Vincent, officers from Ministry of Health of China, Secretary General of Shanghai Skin Diseases Hospital and others Government officers and renowned scientists.
The purpose of the Consortium is to promote the development of AI in the medical research and the use of AI in the medical industry. The Consortium members unanimously endorses and adopts the use of RYC as the technology of Artificial Intelligence and Block Chain for the research and clinical study in various medical specialties and Shanghai Skin Diseases Hospital has already set up a RYC Block Chain and Artificial Intelligence Center for Medicine. The use of RYC will be promoted to the doctors and patients in these countries through the Consortium.
“Incorporating Artificial Intelligence technology into the conventional medicines is definitely the future of medicine, not just in the area of diagnosis, but also in the area of treatment. We are pleased to be part of this growing trend,” said Prof. Akhmedov. “AI is powered not just by the software, more importantly the semiconductor and nanotechnology. We have already seen nanotechnology is used in some of the treatment of diseases and our research institute will collaborate with Key ASIC to further engage in the use of AI in medicines.”
“Undoubtedly, AI and Block Chain technologies will revolutionize the medical industry. We see AI technology is being used in the diagnosis of the images and many of the routine procedures are done by robots. AI specialist is going to be a reality and we are actively engaged in the research and clinical trial of these projects,” commented Prof. Prakash Vincent.
“We are pleased to be a founding member of the Consortium and that our technologies are going to be used not just in the hospitals but also leading research institutes and universities in the BRICS countries. We will continue to play active role in many of the leading-edge projects with the members of the Consortium and we expect more breakthroughs in the medicine based on AI,” said Eg Kah Yee, Chairman of Key ASIC.
BRICS countries have a total population of about 40% the world population and earned their reputation as major economy due to their rapid economic growth over the last three decades.

KEY ASIC A FOUNDING MEMBER OF BRICS ARTIFICIAL INTELLIGENCE (AI) MEDICINE CONSORTIUM

(Kuala Lumpur, July 12, 2018) Following the latest product announcement of the AI Block Chain Device called Ramon Y Cajal or RYC, Key ASIC Berhad (Stock Code: 0143) announced today that it has spearheaded the formation of BRICS Artificial Intelligence Medicine Consortium (AI) in Shanghai, China. The BRICS countries consists of Brazil, Russia, India, China and South Africa. Key ASIC led the initiative and is a founding member of this consortium.
The signing ceremony was well represented and attended by high ranking officials from the BRICS countries including the Special Envoy of Deputy Prime Minister of Russia Dr. Vasilli Shpak, the Chairman of BRICS Bio-Medicine from Russia, Professor Shamil Akhmedov, Chairman of BRICS Bio-Medicine from India Professor Prakash Vincent, officers from Ministry of Health of China, Secretary General of Shanghai Skin Diseases Hospital and others Government officers and renowned scientists.
The purpose of the Consortium is to promote the development of AI in the medical research and the use of AI in the medical industry. The Consortium members unanimously endorses and adopts the use of RYC as the technology of Artificial Intelligence and Block Chain for the research and clinical study in various medical specialties and Shanghai Skin Diseases Hospital has already set up a RYC Block Chain and Artificial Intelligence Center for Medicine. The use of RYC will be promoted to the doctors and patients in these countries through the Consortium.
“Incorporating Artificial Intelligence technology into the conventional medicines is definitely the future of medicine, not just in the area of diagnosis, but also in the area of treatment. We are pleased to be part of this growing trend,” said Prof. Akhmedov. “AI is powered not just by the software, more importantly the semiconductor and nanotechnology. We have already seen nanotechnology is used in some of the treatment of diseases and our research institute will collaborate with Key ASIC to further engage in the use of AI in medicines.”
“Undoubtedly, AI and Block Chain technologies will revolutionize the medical industry. We see AI technology is being used in the diagnosis of the images and many of the routine procedures are done by robots. AI specialist is going to be a reality and we are actively engaged in the research and clinical trial of these projects,” commented Prof. Prakash Vincent.
“We are pleased to be a founding member of the Consortium and that our technologies are going to be used not just in the hospitals but also leading research institutes and universities in the BRICS countries. We will continue to play active role in many of the leading-edge projects with the members of the Consortium and we expect more breakthroughs in the medicine based on AI,” said Eg Kah Yee, Chairman of Key ASIC.
BRICS countries have a total population of about 40% the world population and earned their reputation as major economy due to their rapid economic growth over the last three decades.

announcement from brother company..... keyasic

next swing will be above 50 sen

T3/T4 guys will get burnt. If Bramal keeps buying, why u takut?

something big coming up soon...

big announcement after Raya..

brahma buying up....

T3/T4 guys run liao...

@prc4wifefe -- you are right about myeg contracts... u so damm good with your forecast!!!

PE less than 10... very cheap buy for funds